LipoKinetix Cases Prompt Support For Mandatory Supplement AE Reporting
This article was originally published in The Tan Sheet
Executive Summary
Seven hepatotoxicity adverse event reports linked to Syntrax' LipoKinetix weight-loss supplement further support the need for mandatory AE reporting for supplement manufacturers, University of Pennsylvania researchers say
You may also be interested in...
Food Stamp Coverage For Supplements, Release Of GMPs Urged By NNFA
Passage of the farm bill food stamp provision is among the key legislative initiatives being pushed by the National Nutritional Foods Association, the trade group noted at a Capitol Hill workshop in Washington, D.C. March 19
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee
GMPs, Food Safety, Industry Guidances Among CFSAN’s 2002 Top Priorities
Industry guidances on dietary supplement regulations and labeling issues are slated to be released by FDA's Center for Food Safety & Applied Nutrition over the next two years